Sorrento Tech, Inc. ROKA
Set alert
No live quote for ROKA yet.
- Open
- 0.6844
- Prev close
- 0.6699
- Mkt cap
- 3.25M
- Vol
- 242.29K
- Avg vol
- 265.47K
- EPS
- -8.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.65
- High
- 0.69
- Forward P/E
- -0.15
- Beta
- 2.40
- Short ratio
- 0.45
- Inst. own
- 44.13%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.725852
- 200-d avg
- 1.29
- 1y target
- 10.00
Key statistics
- Market cap
- 3.25M
- Enterprise value
- 2.11M
- Trailing P/E
- 0.00
- Forward P/E
- -0.15
- PEG ratio
- 0.00
- Price / sales
- 0.41
- Price / book
- 0.26
- EPS (TTM)
- -8.33
- Beta
- 2.40
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 7.99M
- Revenue growth
- 1.20%
- Free cash flow
- -9.65M
- Total cash
- 1.76M
- Total debt
- 610.00K
- Return on equity
- -115.94%
- Shares outstanding
- 5.01M
- Short % of float
- 18.65%
- 50-day average
- 0.725852
- 200-day average
- 1.29
Analyst view
Consensus: buy
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 12, 2016 | Roth Capital | init | — | Buy |
| Mar 6, 2016 | Leerink Swann | down | — | Market Perform |
| Aug 13, 2015 | Leerink Swann | main | — | Outperform |
| Nov 6, 2014 | Bank of America | down | — | Neutral |
| Aug 10, 2014 | Cowen & Co. | init | — | Outperform |
| Aug 10, 2014 | Leerink Swann | init | — | Outperform |
About Sorrento Tech, Inc.
Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single and integrated platform. The company also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies. It serves food processors, third-party contract testing laboratories, and government regulatory authorities. The company was founded in 2009 and is headquartered in Warren, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Laboratories & Research
- Country
- United States
- Website
- rokabio.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on ROKA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOESGAARD LARS | Officer | Acquisition (Non Open Market) | Nov 9, 2016 | 8,938 |
| MARY BETH DUSEAU | Officer | Acquisition (Non Open Market) | Nov 9, 2016 | 1,429 |
| ORBIMED ADVISORS LLC | Beneficial Owner (10% or more) | Sale | Oct 2, 2017 | 0 |
| THOMAS PAUL | Officer | Acquisition (Non Open Market) | Nov 9, 2016 | 85,494 |
| TPG GROUP HOLDINGS (SBS) ADVISORS, INC. | Beneficial Owner (10% or more) | Acquisition (Non Open Market) | Nov 9, 2016 | 0 |
| VALERIANI NICHOLAS J | Director | Acquisition (Non Open Market) | Nov 9, 2016 | 7,143 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| NEA Management Company, LLC | 17.85% | 893,471 | 821.99K | Sep 29, 2017 |
| TPG Group Holdings (SBS) Advisors, Inc. | 17.39% | 870,357 | 800.73K | Sep 29, 2017 |
| Sabby Management, LLC | 4.74% | 237,322 | 218.34K | Sep 29, 2017 |
| Orbimed Advisors LLC. | 4.03% | 201,617 | 185.49K | Sep 29, 2017 |
| Renaissance Technologies, LLC | 1.67% | 83,790 | 77.09K | Sep 29, 2017 |
| Virtu Financial LLC | 1.17% | 58,663 | 53.97K | Sep 29, 2017 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.41% | 20,286 | 55.18K | Jun 29, 2017 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.34% | 16,950 | 46.10K | Jun 29, 2017 |
| Fidelity Total Market Index Fund | 0.20% | 10,160 | 12.19K | Oct 30, 2017 |
| Claymore ETF Tr-Wilshire Micro Cap ETF | 0.08% | 4,208 | 3.87K | Sep 29, 2017 |
| Fidelity Extended Market Index Fund | 0.04% | 1,791 | 2.15K | Oct 30, 2017 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 282 | 259 | Sep 29, 2017 |